Press release
Global Oncolytic Virus Therapy Market size, share, market intelligence, company profiles, market trends, growth, strategy, research report, analysis, overview, forecast 2018-2023
According to OMR analysis, the Global Oncolytic Virus Therapy Market is estimated to grow at a significant CAGR during the forecast period (2018-2023). Oncolytic virus therapy is based on the treatment through a virus that infects and kills cancer cells. These oncolytic viruses not only destroy the cancerous cell, also prevents the growth of tumor cells by stimulating the host anti-tumor immune responses. The first oncolytic virus therapy was approved in 2015, it is still is in the nascent stage of being considered as suitable and effective cancer therapy. The first oncolytic virus was the genetically modified herpes simplex virus type I that is Talimogene laherparepvec (T-VEC) that reported to be clinically beneficial for patients with melanoma. Oncolytic virus therapy market is anticipated to grow at a decent growth rate during the forecast period. Most of the oncolytic virus therapy in clinical trials are in preclinical phase followed by Phase-I trials. At present, two three oncolytic drugs have been commercialized, however, approximately 48 oncolytic virus therapies are in clinical trials. The factors that are fuelling the growth of the market includes higher incidence and prevalence rate of cancer.A full report of Global Oncolytic Virus Therapy Market is available at https://www.omrglobal.com/industry-reports/oncolytic-virus-therapy-market/
Furthermore, the Global Oncolytic Virus Therapy Market is segmented into by type, by use, by product and by end-user. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.
Market Segmentation
1. Global Market, By Product
• HSV-Based Oncolytic Viruses
• Adenoviruses-Based Oncolytic Viruses
• Vaccinia Virus-Based Oncolytic Viruses
• Vesicular Stomatitis Virus-Based Oncolytic Viruses
• Newcastle Disease Virus-Based Oncolytic Viruses
2. Global Market, By Application
• Prostate Cancer
• Breast Cancer
• Ovarian Cancer
• Others
Region Covered
• North America (the US and Canada)
• Europe (UK, Germany, France, Spain, Italy, and ROE)
• Asia-Pacific (China, India, Japan, and ROAP)
• Rest of the World
Company Profile
• Amgen
• BioVex Inc.,
• Cold Genesys, Inc.
• Crusade Laboratories
• Cynvec LLC
• Genelux Corp.
• JennerRex Co. Ltd
• Lokon Pharma AB
• MediGene AG
• Merck
• Neotropix, Inc.
• Oncolys BioPharma
• Oncolytics Biotech, Inc.
• Onyx
• Otsuka Pharmaceuticals Co. Ltd
• PsiOxus Therapeutics Ltd
• Roche
• Shanghai Sunway Biotech Co. Ltd
• Silajen Biotherapeutics, Inc.
• Sorrento Therapeutics
• SunWay Biotech Co. Ltd
• Takara Bio, Inc.
• Targovax
• Theravir
• TILT Biotherapeutics
• Transgene SA
• VCN Biosciences SL
• Viralytics Ltd
• Vyriad
For related reports please visit https://www.omrglobal.com/reports-category/pharmaceuticals/
For more update follow LinkedIn https://www.linkedin.com/company/omr-global-research/
About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.
Contact us
Orion Market Research Pvt. Ltd.
Anurag Tiwari
Email: info@omrglobal.com
India: +91 7803040404
Global:+1 6467557667
Indore-India-452010
Web: www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Oncolytic Virus Therapy Market size, share, market intelligence, company profiles, market trends, growth, strategy, research report, analysis, overview, forecast 2018-2023 here
News-ID: 1663574 • Views: …
More Releases from Orion Market Research

Smart Furniture Market - Industry Trends and Forecast to 2032 Growth, Share, Val …
The global smart furniture market was valued at approximately USD 3.11 billion in 2023 and is projected to reach USD 4.66 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.6% from 2024 to 2032.
Smart Furniture Market Overview
Smart furniture integrates technology into traditional furniture designs to enhance functionality and user experience. Features such as wireless charging, voice-activated controls, and adjustable settings cater to the growing…

Moringa Products Market: Emerging Trends and Growth Forecast to 2032
The global moringa products market was valued at approximately USD 6.2 billion in 2023 and is projected to reach around USD 12.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.6% from 2024 to 2032.
Moringa Products Market Overview
Moringa, often referred to as the "drumstick tree" or "miracle tree," is renowned for its rich nutritional profile, encompassing vitamins, minerals, antioxidants, and essential amino acids. The…

Maternity Wear Market: Emerging Trends and Growth Forecast to 2033
The global maternity wear market was valued at approximately USD 19.98 billion in 3 and is projected to reach USD 44.24 billion by 2033, growing at a compound annual growth rate (CAGR) of 8.27% from 2024 to 2033.
Maternity Wear Market Overview
The maternity wear market has experienced significant growth in recent years, driven by increasing awareness about the importance of comfortable and functional clothing during pregnancy. As more women…

Transvaginal Endoscopy Market: Emerging Trends and Growth Forecast to 2030
The global transvaginal endoscopy market was valued at approximately USD 2.5 billion in 2022 and is projected to reach USD 4.8 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2024 to 2030.
Transvaginal Endoscopy Market Overview
Transvaginal endoscopy is a minimally invasive diagnostic procedure used to examine female reproductive organs, including the uterus, ovaries, and fallopian tubes. The market's growth is driven by factors such…
More Releases for Oncolytic
Oncolytic Virus Market: Know Applications Supporting Impressive Growth
A new business intelligence report released by HTF MI with title "Global Oncolytic Virus Market Professional Survey Report 2019" is designed covering micro level of analysis by manufacturers and key business segments. The Global Oncolytic Virus Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative…
Oncolytic Virus Therapy Market Oncolytic Virus Therapy Clinical Pipeline Report …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Prologue to Oncolytic Virus
1.1 Outline of Oncolytic Virotherapy
1.2 Trail from Genesis to Biogenetics
Primer of Virotherapy in Malignancies
2.1 Oncolytic Viruses towards Cancer
2.2 Approaches for Targeting Tumor Cells
2.2.1 Pro Apoptotic Targeting
2.2.2 Translational Targeting
2.2.3 Transcriptional Targeting
2.2.4 Transductional Targeting
Mechanism…
Global Oncolytic Virus Therapy Report Highlight Market Opportunity & Insight On …
“Global Oncolytic Virus Therapy Market and Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the oncolytic virus therapy market. Currently there are 2 oncolytic virus therapies commercially available in the market. This report analyzes the ongoing clinical trial of 48 oncolytic virus therapies in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the oncolytic virus therapies. Most of the oncolytic…
Global Oncolytic Virus Therapy Market & Oncolytic Virus clinical Trials Outlook …
Advancements in human genomics over the last two decades have shown that cancer is mediated by somatic aberration in the host genome. This discovery has incited enthusiasm among cancer researchers; many now use therapeutic approaches in genetic manipulation to improve cancer regression and find a potential cure for the disease.
The dominant cancer treatment modalities such as chemotherapy, radiotherapy, and even targeted kinase inhibitors and mAbs are limited by low…
Global Oncolytic Virus Therapy Pipeline Analysis
Though still in nascent stages, Oncolytic viruses have shown immense opportunities and potential to be tapped in the future to improve the treatment of cancer and the lives of the patients. Immunotherapy, the umbrella for Oncolytic viruses would not offer cures, but survival solutions with significant importance. Also, the side effects of this therapy would be tolerable by the patients, which could thus become the most important approach to treat…
Global Oncolytic Virus Therapy Market and Pipeline Outlook 2022
“Global Oncolytic Virus Therapy Market and Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the oncolytic virus therapy market. Currently there are 2 oncolytic virus therapies commercially available in the market. This report analyzes the ongoing clinical trial of 48 oncolytic virus therapies in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the oncolytic virus therapies. Most of the oncolytic…